Secondary analysis of a randomised trial in 65 healthy Malawian adults: PCV13 raised serum and nasal IgG and blood IgG+ B cells against pneumococcal serotype 6B but not serotype 3.
Secondary analysisn = 65
Tembo et al. 13-valent pneumococcal conjugate vaccine-induced B cells produce serotype 6B but not serotype 3 capsule-specific IgG antibodies in young Malawian adults